Therapies

This highly anticipated psychedelic docuseries showcases what these substances teaches people about consciousness, dying, addiction, depression and transcendence. Filmmaker Alex Gibney and best-selling author Michael Pollan present it in four parts, each focused on a different mind-altering substance: LSD, psilocybin, MDMA, and mescaline. With Pollan as our guide, we journey to the frontiers of the new psychedelic renaissance -- and look back at almost-forgotten historical context -- to explore the potential of these substances to heal and change minds as well as culture.
The first chapter is a great introduction to the topic of LSD, from its 1943 origins to today's microdosing trend, for those who don’t already know a lot about the subject, and a fun and entertaining refresher on LSD for even experts in the field. The show takes us on a journey through the history of the powerful compound, from its discovery and its early medical use, to secret CIA mind-control studies, the counterculture and its banning, and finally to our current renaissance. It includes amazing clips of LSD’s inventor Albert Hofmann and powerful personal testimonies of individuals who have healed their suffering through LSD.

A huge social experiment is underway. Fifty-five million Americans say they currently use cannabis, and that number is expected to grow as voters push for legalization in more and more states. The film investigates the story of cannabis from the criminalization that has disproportionately harmed communities of color to the latest medical understanding of the plant.
What risks does cannabis pose to the developing brain? How much do we know about its potential medical benefits? As cannabis becomes socially accepted, scientists are exploring its long-term health consequences.

The Last Shaman James is an all American boy whose promising life is brought to a halt by acute depression. Turning his back on the most progressive western treatments and medicines, James discovers ayahuasca in search of healing in the Peruvian jungle. Over the course of 10 months venturing from Shaman to Shaman, James finds friendship, answers and a kind of redemption hidden deep in the Peruvian amazon. (Click CC for subtitles)

A ground-breaking new trial at Imperial College London sees, for the first time ever under controlled conditions, a psychedelic drug tested head-to-head against a standard antidepressant as a treatment for depression. The film follows a pioneering team of scientists and psychotherapists as they compare the effects of psilocybin (the active ingredient of magic mushrooms) with an antidepressant on a small group of participants with clinical depression.
This is scientific research at its most cutting edge. With over seven million people being prescribed antidepressants each year in England alone, this drug trial is an important milestone in understanding a completely different treatment for depression. How do psychedelic drugs measure up against the industry-standard antidepressants that have been popular since the 1990s? The empirical results of the trial are explored alongside the participants’ powerful lived experience.

Michael Moore’s documentary sets out to investigate the highly profitable American health care industry, compares it to other nations and shows HMO horror stories. Sticking to his tried-and-true one-man approach, Moore sheds light on the complicated medical affairs of individuals and local communities. Sicko is as indicting as the rest of Moore’s films.

Where will loved ones spend their last days? Who will be in the room? What feelings and secrets need to be shared with family before it is too late? Acclaimed filmmakers Rob Epstein and Jeffrey Friedman probe these questions and more in the context of two San Francisco Bay Area medical facilities on the forefront of creating new paradigms for end of life decisions with grace.
Filmed and edited in intimate vérité style, 'End Game' follows visionary medical practitioners who are working on the cutting edge of life and death and are dedicated to changing our thinking about both.